Immunosenescence contributes to the decreased ability of the elderly to control infectious diseases, which is also reflected in their generally poor response to new antigens and vaccination. It is known that the T cell branch of the immune system is impaired in the elderly mainly due to expansion of memory/effector cells that renders the immune system less able to respond to new antigens. B lymphocytes are also impaired in the elderly in terms of their response to new antigens. In this paper we review recent work on B cell immunosenescence focusing our attention on memory B cells and a subset of memory B cells (namely IgG + IgD − CD27 − ) that we have demonstrated is increased in healthy elderly.
Introduction
In human ageing the ability to respond to vaccines and new infectious agents is impaired, mainly because of changes in adaptive immunity mediated by T and B cells. This phenomenon called 'immunosenescence' is influenced by environmental and genetic factors, but also by the antigenic load to which individuals are exposed throughout life, and this has an impact on immune performance in late life (Pawelec and Larbi, 2008; van Baarle et al., 2005) .
Immunosenescence materially contributes to the decreased ability of the elderly to respond to new antigens and vaccinations and to control infectious diseases (Gardner et al., 2006; Genton et al., 2006) . Indeed, ageing is associated with an increased incidence of infections such as viral influenza, respiratory syncitial virus (RSV) and pneumococcal pneumonia (Nicholson et al., 1997) . Elderly people also have an increased incidence of bacterial infections in lungs, urinary tract, skin and other tissues and a higher incidence of tuberculosis and herpes zoster reactivation (Ginaldi et al., 2001) . Vaccinations are powerful tools in order to prevent morbidity and mortality from infections in people over the age of 65 years, however, because of the impairment of immune functions with ageing, the currently available vaccines protect only * Corresponding author. Tel.: +39 0916555906; fax: +39 0916555933.
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Although most of the literature on immunosenescence have focused on T cell impairment, B cell compartment is also defective in the elderly: indeed humoral immune response is modified in the elderly both in the quality and quantity of the antibodies produced, and the number of circulating B cells is reduced in the aged (Cancro et al., 2009; Frasca et al., 2010b) .
In addition it is known that, B cells have effector and regulatory functions other than antibody production (Sanz et al., 2007; Martin and Chan, 2006; Harris et al., 2000) and memory and naïve B cells can produce different cytokines and chemokines; in particular memory B cells produce high levels of the proinflammatory cytokines IL-1␣, IL-1␤, IL-6 and TNF-␣ so suggesting that B cells might take part in the generation or in the maintenance of the inflammatory environment of the elderly (Agrawal and Gupta, 2010) . Indeed a typical feature of ageing is the pro-inflammatory status observed in the elderly, related to chronic inflammatory diseases. So, ageing increases risk of disability and chronic diseases, with many older adults experiencing multiple chronic conditions in old age. Some evidence exists to support theories that increased health risks in old age are the result of environmental stressors that accumulate over time. These stressors potentially can disrupt the regulation of biological systems, however, not all individuals or population groups seem to be equally susceptible to the effects of stress. Questions remain as which factors mediate biological
